Monographie - Epirubicin hydrochloride

Viimane versioon :
08/05/2024

Epirubicin hydrochloride

Keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Anthracine	Malaisia
Axirubicine	Saksamaa
Bendaepi	Saksamaa
Binarin	Mehhiko
Bioepycina	Poola
Crisabon	Argentiina
Cuatroepi	Argentiina
Ecclepia	Rumeenia
Elebicin	Mehhiko
Ellence	Ameerika ühendriigid
Epi Cell	Saksamaa
Epidoxo	Argentiina, Tšiili, Venetsueela
Epifil	Ecuador
Epilem	Kolumbia, Mehhiko
Epimedac	Saksamaa
Epirubicin	Austraalia, Austria, Belgia, Island, Rootsi, Saudi Araabia, Suurbritannia, Sveits, Taani, Türgi, Ungari, Uus-Meremaa
Epirubicina	Argentiina, Ecuador, Hispaania, Kolumbia, Mehhiko, Rumeenia
Epirubicine	Belgia, Prantsusmaa, Sveits
Farmarubicin	Türgi
Farmorubicin	Austria, Brasiilia, Kreeka, Norra, Rootsi, Saudi Araabia, Soome, Sveits, Taani
Farmorubicin CSV	Lõuna Aafrika Vabariik
Farmorubicin PFS	Horvaatia, Poola, Sloveenia
Farmorubicin RD	Brasiilia, Poola, Sveits, Vene
Farmorubicin RTU	Holland
Farmorubicina	Brasiilia, Hispaania, Itaalia, Portugal
Farmorubicine	Belgia, Prantsusmaa
Pharmorubicin	Suurbritannia

Viited : Epirubicin hydrochloride

	Tüüp	Avaldamine
148	Ajaleht	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Ajaleht	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Ajaleht	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Ajaleht	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Ajaleht	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Ajaleht	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Ajaleht	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Ajaleht	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Ajaleht	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Ajaleht	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Ajaleht	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Ajaleht	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Ajaleht	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Labor	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Ajaleht	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Labor	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Labor	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Ajaleht	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	Plakat	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Ajaleht	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Ajaleht	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales